This invention relates to TASK-1 and/or TASK-3 antagonists and/or their pharmaceutically acceptable salts, compositions and methods for treating and preventing disorders which are caused by activation or by an activated TASK-1 and/or TASK-3, and disorders
-
(2011/09/21)
TASK CHANNEL ANTAGONISTS
This invention relates to TASK-1 and/or TASK-3 antagonists and/or their pharmaceutically acceptable salts, compositions and methods for treating and preventing disorders which are caused by activation or by an activated TASK-1 and/or TASK-3, and disorders
-
(2011/09/30)
More Articles about upstream products of 1332453-16-3
Get Best Price for1332453-16-3cyclopropyl(l-{6-[(4'-fluorobiphenyl-4-yl)carbonyl]-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl}piperidin-4-yl)methanone